Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NAFARELIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 125 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wong, JM; Forrest, KA; Snabes, MC; Zhao, SZ; Gersh, GE; Kennedy, SH
      Efficacy of nafarelin in assisted reproductive technology: a meta-analysis

      HUMAN REPRODUCTION UPDATE
    2. Rossi, R; Tauchmanova, L; Luciano, A; Valentino, R; Savastano, S; Battista, C; Di Martino, M; Lombardi, G
      Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by apparently idiopathic hirsutism

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    3. Hirosue, S; Muller, BG; Mulligan, RC; Langer, R
      Plasmid DNA encapsulation and release from solvent diffusion nanospheres

      JOURNAL OF CONTROLLED RELEASE
    4. Leder, BZ; Smith, MR; Fallon, MA; Lee, MLT; Finkelstein, JS
      Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    5. Takeuchi, S; Minoura, H; Shibahara, T; Tsuiki, Y; Noritaka, F; Toyoda, N
      A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection

      FERTILITY AND STERILITY
    6. Bergqvist, A; Theorell, T
      Changes in quality of life after hormonal treatment of endometriosis

      ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
    7. Illum, L; Watts, P; Fisher, AN; Gill, IJ; Davis, SS
      Novel chitosan-based delivery systems for the nasal administration of a LHRH-analogue

      STP PHARMA SCIENCES
    8. Nakao, A; Iwagaki, H; Kanagawa, T; Jikuhara, A; Matsubara, N; Takakura, N; Isozaki, H; Tanaka, N
      Crohn's disease mimicking as bowel endometriosis - Are the symptoms reduced by nafarelin acetate?

      ARCHIVES OF GYNECOLOGY AND OBSTETRICS
    9. Schwahn, M; Schupke, H; Gasparic, A; Krone, D; Peter, G; Hempel, R; Kronbach, T; Locher, M; Jahn, W; Engel, J
      Disposition and metabolism of cetrorelix, a potent luteinizing hormone-releasing hormone antagonist, in rats and dogs

      DRUG METABOLISM AND DISPOSITION
    10. Kurabayashi, T; Takakuwa, K; Tanaka, K
      Treatment with nafarelin for endometriosis in young women - Efficacy, safety and lipid metabolism

      JOURNAL OF REPRODUCTIVE MEDICINE
    11. Minaguchi, H; Wong, JM; Snabes, MC
      Clinical use of nafarelin in the treatment of leiomyomas - A review of theliterature

      JOURNAL OF REPRODUCTIVE MEDICINE
    12. Pierce, SJ; Gazvani, MR; Farquharson, RG
      Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a6-year follow-up

      FERTILITY AND STERILITY
    13. Platteau, P; Gabbe, M; Famelos, M; Kovacs, G; Healy, D
      Should we still advise infertile couples to use (barrier) contraception before IVF down-regulation?

      FERTILITY AND STERILITY
    14. Cheung, TH; Lo, KWK; Lam, CWK; Lau, WC; Lam, PKW
      A crossover study of triptorelin and leuprorelin acetate

      FERTILITY AND STERILITY
    15. Matalliotakis, IM; Koumantaki, YG; Neonaki, MA; Goumenou, AG; Koumantakis, GE; Kyriakou, DS; Koumantakis, EE
      Increase in serum leptin concentrations among women with endometriosis during danazol and leuprolide depot treatments

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    16. Potau, N; Ibanez, L; Sentis, M; Carrascosa, A
      Sexual dimorphism in the maturation of the pituitary-gonadal axis, assessed by GnRH agonist challenge

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    17. Adamson, GD
      A 36-year-old woman with endometriosis, pelvic pain, and infertility

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    18. Ling, FW
      Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis

      OBSTETRICS AND GYNECOLOGY
    19. Zhao, SZ; Kellerman, LA; Francisco, CA; Wong, JM
      Impact of nafarelin and leuprolide for endometriosis on quality of life and subjective clinical measures

      JOURNAL OF REPRODUCTIVE MEDICINE
    20. Salerno, M; Di Maio, S; Gasparini, N; Mariano, A; Macchia, V; Tenore, A
      Central precocious puberty: A single blood sample after gonadotropin-releasing hormone agonist administration in monitoring treatment

      HORMONE RESEARCH
    21. Mainieri, AS; Viera, JGH; Elnecave, RH
      Response of the free alpha-subunit to GnRH distinguishes individuals with 'functional' from those with permanent hypogonadotropic hypogonadism

      HORMONE RESEARCH
    22. Elgendy, M; Afnan, M; Holder, R; Lashen, H; Afifi, Y; Lenton, W; Sharif, K
      Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome

      HUMAN REPRODUCTION
    23. HIRVONEN J; GUY RH
      TRANSDERMAL IONTOPHORESIS - MODULATION OF ELECTROOSMOSIS BY POLYPEPTIDES

      Journal of controlled release
    24. ZHAO SZ; ARGUELLES LM; WONG JM; DAVIS MB; GERSH GE; STRUTHERS BJ
      COST COMPARISONS BETWEEN NAFARELIN AND LEUPROLIDE IN THE TREATMENT OFENDOMETRIOSIS

      Clinical therapeutics
    25. BARBIERI RL
      ENDOMETRIOSIS AND THE ESTROGEN THRESHOLD THEORY - RELATION TO SURGICAL AND MEDICAL-TREATMENT

      Journal of reproductive medicine
    26. HEINRICHS WL; HENZL MR
      HUMAN ISSUES AND MEDICAL ECONOMICS OF ENDOMETRIOSIS - 3-MONTH VS. 6-MONTH GNRH-AGONIST THERAPY

      Journal of reproductive medicine
    27. CANN CE
      BONE DENSITOMETRY AS AN ADJUNCT TO GNRH AGONIST THERAPY

      Journal of reproductive medicine
    28. MIZUTANI T; SUGIHARA A; NAKAMURO K; TERADA N
      SUPPRESSION OF CELL-PROLIFERATION AND INDUCTION OF APOPTOSIS IN UTERINE LEIOMYOMA BY GONADOTROPIN-RELEASING-HORMONE AGONIST (LEUPROLIDE ACETATE)

      The Journal of clinical endocrinology and metabolism
    29. AMAMA EA; TAGA M; MINAGUCHI H
      THE EFFECT OF GONADOTROPIN-RELEASING-HORMONE AGONIST ON TYPE-I COLLAGEN C-TELOPEPTIDE AND N-TELOPEPTIDE - THE PREDICTIVE VALUE OF BIOCHEMICAL MARKERS OF BONE TURNOVER

      The Journal of clinical endocrinology and metabolism
    30. MOGHISSI KS; SCHLAFF WD; OLIVE DL; SKINNER MA; YIN H
      GOSERELIN ACETATE (ZOLADEX)ASTERISK WITH OR WITHOUT HORMONE REPLACEMENT THERAPY FOR THE TREATMENT OF ENDOMETRIOSIS

      Fertility and sterility
    31. BERGQVIST A; BERGH T; HOGSTROM L; MATTSSON S; NORDENSKJOLD F; RASMUSSEN C
      EFFECTS OF TRIPTORELIN VERSUS PLACEBO ON THE SYMPTOMS OF ENDOMETRIOSIS

      Fertility and sterility
    32. SIMBERG N; TULPPALA M; HUSA LM; TIITINEN A
      COMPARISON OF BUSERELIN AND NAFARELIN IN IVF CYCLES AND IN SUBSEQUENTFROZEN-THAWED EMBRYO-TRANSFER CYCLES

      Acta obstetricia et gynecologica Scandinavica
    33. BERGQVIST A; JACOBSON J; HARRIS S
      A DOUBLE-BLIND RANDOMIZED STUDY OF THE TREATMENT OF ENDOMETRIOSIS WITH NAFARELIN OR NAFARELIN PLUS NORETHISTERONE

      Gynecological endocrinology
    34. HIRVONEN J; GUY RH
      IONTOPHORETIC DELIVERY ACROSS THE SKIN - ELECTROOSMOSIS AND ITS MODULATION BY DRUG SUBSTANCES

      Pharmaceutical research
    35. LANES R; GUNCZLER P; OSUNA JA; PALACIOS A; CARRILLO E; RAMIREZ X; GARCIA C; PAOLI M; VILLAROEL O
      EFFECTIVENESS AND LIMITATIONS OF THE USE OF THE GONADOTROPIN-RELEASING-HORMONE AGONIST LEUPROLIDE ACETATE IN THE DIAGNOSIS OF DELAYED PUBERTY IN MALES

      Hormone research
    36. GAMBACCIANI M; CAPPAGLI B; PIAGGESI L; CIAPONI M; GENAZZANI AR
      IPRIFLAVONE PREVENTS THE LOSS OF BONE MASS IN PHARMACOLOGICAL MENOPAUSE INDUCED BY GNRH-AGONISTS

      Calcified tissue international
    37. MERINO V; KALIA YN; GUY RH
      TRANSDERMAL THERAPY AND DIAGNOSIS BY IONTOPHORESIS

      Trends in biotechnology
    38. AGARWAL SK; HAMRANG C; HENZL MR; JUDD HL
      NAFARELIN VS LEUPROLIDE ACETATE DEPOT FOR ENDOMETRIOSIS - CHANGES IN BONE-MINERAL DENSITY AND VASOMOTOR SYMPTOMS

      Journal of reproductive medicine
    39. HORNSTEIN MD; HEMMINGS R; YUZPE AA; HEINRICHS WL
      USE OF NAFARELIN VERSUS PLACEBO AFTER REDUCTIVE LAPAROSCOPIC SURGERY FOR ENDOMETRIOSIS

      Fertility and sterility
    40. HORNSTEIN MD; YUZPE AA; BURRY K; BUTTRAM VC; HEINRICHS L; SODERSTROM RM; STEINBERGER E; LIN JS
      RETREATMENT WITH NAFARELIN FOR RECURRENT ENDOMETRIOSIS SYMPTOMS - EFFICACY, SAFETY, AND BONE-MINERAL DENSITY

      Fertility and sterility
    41. IBANEZ L; POTAU N; ZAMPOLLI M; STREET ME; CARRASCOSA A
      GIRLS DIAGNOSED WITH PREMATURE PUBARCHE SHOW AN EXAGGERATED OVARIAN ANDROGEN SYNTHESIS FROM THE EARLY STAGES OF PUBERTY - EVIDENCE FROM GONADOTROPIN-RELEASING-HORMONE AGONIST TESTING

      Fertility and sterility
    42. FUJIMOTO VY; MONROE SE; NELSON LR; DOWNEY D; JAFFE RB
      DOSE-RELATED SUPPRESSION OF SERUM LUTEINIZING-HORMONE IN WOMEN BY A POTENT NEW GONADOTROPIN-RELEASING-HORMONE ANTAGONIST (GANIRELIX) ADMINISTERED BY INTRANASAL SPRAY

      Fertility and sterility
    43. TOKUMITSU H; FUKUMORI Y; TSUDA Y; OKADA Y; KASUYA F; IGARASHI K; FUKUI M
      DEGRADATION OF A NOVEL TRIPEPTIDE, TERT-BUTOXYCARBONYL-TYR-LEU-VAL-CH2CL, WITH INHIBITORY EFFECT ON HUMAN-LEUKOCYTE ELASTASE IN AQUEOUS-SOLUTION AND IN BIOLOGICAL-FLUIDS

      Chemical and Pharmaceutical Bulletin
    44. ADAMSON GD; HEINRICHS WL; HENZL MR; YUZPE AA; BERQUIST C; JACOBSON JJ; ERIKSSON S; KWEI L; GILBERT SM
      THERAPEUTIC EFFICACY AND BONE-MINERAL DENSITY RESPONSE DURING AND FOLLOWING A 3-MONTH RETREATMENT OF ENDOMETRIOSIS WITH NAFARELIN (SYNAREL)

      American journal of obstetrics and gynecology
    45. JONES NS; QURAISHI S; MASON JDT
      THE NASAL DELIVERY OF SYSTEMIC DRUGS

      International journal of clinical practice
    46. HIRVONEN J; KALIA YN; GUY RH
      TRANSDERMAL DELIVERY OF PEPTIDES BY IONTOPHORESIS

      Nature biotechnology
    47. CORSON SL; GUTMANN JN; BATZER FR; GOCIAL B
      A DOUBLE-BLIND COMPARISON OF NAFARELIN AND LEUPROLIDE ACETATE FOR DOWN-REGULATION IN IVF CYCLES

      International journal of fertility and menopausal studies
    48. GOLDMAN GA; OVADIA J; FISCH B
      THE IMPACT OF GNRH AGONIST AND MENOTROPIN THERAPY ON LIPOPROTEIN METABOLISM

      Gynecological endocrinology
    49. AVRECH OM; GOLDMAN GA; PINKAS H; AMIT S; NERI A; ZUKERMAN Z; OVADIA J; FISCH B
      INTRANASAL NAFARELIN VERSUS BUSERELIN (SHORT PROTOCOL) FOR CONTROLLEDOVARIAN HYPERSTIMULATION BEFORE IN-VITRO FERTILIZATION - A PROSPECTIVE CLINICAL-TRIAL

      Gynecological endocrinology
    50. BROEKMANS FJ; HEITBRINK MA; HOMPES PGA; SCHOUTE E; FALKE T; SCHOEMAKER J
      QUANTITATIVE MRI OF UTERINE LEIOMYOMAS DURING TRIPTORELIN TREATMENT -REPRODUCIBILITY OF VOLUME ASSESSMENT AND PREDICTABILITY OF TREATMENT RESPONSE

      Magnetic resonance imaging
    51. BAYON AMR; GUY RH
      IONTOPHORESIS OF NAFARELIN ACROSS HUMAN SKIN IN-VITRO

      Pharmaceutical research
    52. AMBROSI B; RE T; PASSINI E; BOCHICCHIO D; FERRARIO R
      VALUE OF BUSERELIN TESTING IN THE EVALUATION OF HIRSUTE WOMEN

      Journal of endocrinological investigation
    53. HEINRICH N; ALBRECHT E; SANDOW J; KERTSCHER U; LORENZ D; OEHLKE J; BERGER H
      DISPOSITION OF H-3 LABELED BUSERELIN CONTINUOUSLY INFUSED INTO RATS

      European journal of drug metabolism and pharmacokinetics
    54. KLETTER GB; ROLFESCURL A; GOODPASTURE JC; SOLISH SB; SCOTT L; HENZL MR; BEITINS IZ
      GONADOTROPIN-RELEASING-HORMONE AGONIST ANALOG (NAFARELIN) - A USEFUL DIAGNOSTIC AGENT FOR THE DISTINCTION OF CONSTITUTIONAL GROWTH DELAY FROM HYPOGONADOTROPIC HYPOGONADISM

      Journal of pediatric endocrinology & metabolism
    55. JENKINS JM
      THE INFLUENCE, DEVELOPMENT AND MANAGEMENT OF FUNCTIONAL OVARIAN CYSTSDURING IVF CYCLES

      Human reproduction
    56. CIRKEL U
      MEDICAL-TREATMENT OF SYMPTOMATIC ENDOMETRIOSIS

      Human reproduction
    57. RANA N; THOMAS S; ROTMAN C; DMOWSKI WP
      DECREASE IN THE SIZE OF OVARIAN ENDOMETRIOMAS DURING OVARIAN SUPPRESSION IN STAGE-IV ENDOMETRIOSIS - ROLE OF PREOPERATIVE MEDICAL-TREATMENT

      Journal of reproductive medicine
    58. ROSENFIELD RL
      EVIDENCE THAT IDIOPATHIC FUNCTIONAL ADRENAL HYPERANDROGENISM IS CAUSED BY DYSREGULATION OF ADRENAL STEROIDOGENESIS AND THAT HYPERINSULINEMIA MAY BE INVOLVED

      The Journal of clinical endocrinology and metabolism
    59. TSENG JF; RYAN IP; MILAM TD; MURAI JT; SCHRIOCK ED; LANDERS DV; TAYLOR RN
      INTERLEUKIN-6 SECRETION IN-VITRO IS UP-REGULATED ECTOPIC AND EUTOPIC ENDOMETRIAL STROMAL CELLS FROM WOMEN WITH ENDOMETRIOSIS

      The Journal of clinical endocrinology and metabolism
    60. IBANEZ L; HALL JE; POTAU N; CARRASCOSA A; PRAT N; TAYLOR AE
      OVARIAN 17-HYDROXYPROGESTERONE HYPERRESPONSIVENESS TO GONADOTROPIN-RELEASING-HORMONE (GNRH) AGONIST CHALLENGE IN WOMEN WITH POLYCYSTIC-OVARY-SYNDROME IS NOT MEDIATED BY LUTEINIZING-HORMONE HYPERSECRETION - EVIDENCE FROM GNRH AGONIST AND HUMAN CHORIONIC-GONADOTROPIN STIMULATION TESTING

      The Journal of clinical endocrinology and metabolism
    61. RITTMASTER RS; ARAB DM; LEHMAN L
      DOSE-RESPONSE EFFECT OF DEPOT LEUPROLIDE ACETATE ON SERUM ANDROGENS IN HIRSUTE WOMEN

      Fertility and sterility
    62. MAKARAINEN L; RONNBERG L; KAUPPILA A
      MEDROXYPROGESTERONE ACETATE SUPPLEMENTATION DIMINISHES THE HYPOESTROGENIC SIDE-EFFECTS OF GONADOTROPIN-RELEASING-HORMONE AGONIST WITHOUT CHANGING ITS EFFICACY IN ENDOMETRIOSIS

      Fertility and sterility
    63. BERGFELD EGM; DOCCHIO MJ; KINDER JE
      PITUITARY-FUNCTION, OVARIAN FOLLICULAR-GROWTH, AND PLASMA-CONCENTRATIONS OF 17-BETA-ESTRADIOL AND PROGESTERONE IN PREPUBERTAL HEIFERS DURING AND AFTER TREATMENT WITH THE LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST DESLORELIN

      Biology of reproduction
    64. WINGFIELD M
      GOSERELIN DEPOT VERSUS DANAZOL IN THE TREATMENT OF ENDOMETRIOSIS - THE AUSTRALIAN NEW-ZEALAND EXPERIENCE

      Australian and New Zealand Journal of Obstetrics and Gynaecology
    65. BROEKMANS FJ; HOMPES PGA; HEITBRINK MA; NETELENBOS CC; ROOS JC; FALKE TM; SCHOEMAKER J
      2-STEP GONADOTROPIN-RELEASING-HORMONE AGONIST TREATMENT OF UTERINE LEIOMYOMAS - STANDARD-DOSE THERAPY FOLLOWED BY REDUCED-DOSE THERAPY

      American journal of obstetrics and gynecology
    66. TAGA M; MINAGUCHI H
      REDUCTION OF BONE-MINERAL DENSITY BY GONADOTROPIN-RELEASING-HORMONE AGONIST, NAFARELIN, IS NOT COMPLETELY REVERSIBLE AT 6 MONTHS AFTER THE CESSATION OF ADMINISTRATION

      Acta obstetricia et gynecologica Scandinavica
    67. MIZUTANI T; SAKATA M; TERAKAWA N
      EFFECT OF GONADOTROPIN-RELEASING-HORMONE AGONISTS, NAFARELIN, BUSERELIN, AND LEUPROLIDE, ON EXPERIMENTALLY-INDUCED ENDOMETRIOSIS IN THE RAT

      International journal of fertility and menopausal studies
    68. SCHMIDTSAROSI C; KAPLAN DR; SAROSI P; ESSIG MN; LICCIARDI FL; KELTZ M; LEVITZ M
      OVULATION TRIGGERING IN CLOMIPHENE CITRATE-STIMULATED CYCLES - HUMAN CHORIONIC-GONADOTROPIN VERSUS A GONADOTROPIN-RELEASING-HORMONE AGONIST

      Journal of assisted reproduction and genetics
    69. TANOS V; FRIEDLER S; SHUSHAN A; STRAUSS N; HETSRONI I; LEWIN A
      COMPARISON BETWEEN NAFARELIN ACETATE AND D-TRP6-LHRH FOR TEMPORARY PITUITARY SUPPRESSION IN IN-VITRO FERTILIZATION (IVF) PATIENTS - A PROSPECTIVE CROSSOVER STUDY

      Journal of assisted reproduction and genetics
    70. DELGADOCHARRO MB; GUY RH
      IONTOPHORETIC DELIVERY OF NAFARELIN ACROSS THE SKIN

      International journal of pharmaceutics
    71. CIRKEL U; OCHS H; SCHNEIDER HPG
      A RANDOMIZED, COMPARATIVE TRIAL OF TRIPTORELIN DEPOT (D-TRP(6)-LHRH) AND DANAZOL IN THE TREATMENT OF ENDOMETRIOSIS

      European journal of obstetrics, gynecology, and reproductive biology
    72. YLIKORKALA O; TIITINEN A; HULKKO S; KIVINEN S; NUMMI S
      DECREASE IN SYMPTOMS, BLOOD-LOSS AND UTERINE SIZE WITH NAFARELIN ACETATE BEFORE ABDOMINAL HYSTERECTOMY - A PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY

      Human reproduction
    73. LOCKWOOD GM; PINKERTON SM; BARLOW DH
      A PROSPECTIVE RANDOMIZED SINGLE-BLIND COMPARATIVE TRIAL OF NAFARELIN ACETATE WITH BUSERELIN IN LONG-PROTOCOL GONADOTROPIN-RELEASING-HORMONEANALOG CONTROLLED IN-VITRO FERTILIZATION CYCLES

      Human reproduction
    74. BERGQVIST IA
      HORMONAL-REGULATION OF ENDOMETRIOSIS AND THE RATIONALES AND EFFECTS OF GONADOTROPIN-RELEASING-HORMONE AGONIST TREATMENT - A REVIEW

      Human reproduction
    75. DELGADOCHARRO MB; RODRIGUEZBAYON AM; GUY RH
      IONTOPHORESIS OF NAFARELIN - EFFECTS OF CURRENT-DENSITY AND CONCENTRATION ON ELECTROTRANSPORT IN-VITRO

      Journal of controlled release
    76. NIWA T; TAKEUCHI H; HINO T; KAWASHIMA Y
      AEROSOLIZATION OF LACTIDE GLYCOLIDE COPOL YMER (PLGA) NANOSPHERES FORPULMONARY DELIVERY OF PEPTIDE-DRUGS

      Yakugaku zasshi
    77. FRASER IS
      GNRH AGONISTS FOR ENDOMETRIOSIS

      Medical journal of Australia
    78. SHEK YH; DELIA JE; PATTILLO RA
      ENDOMETRIOSIS WITH A PLEURAL EFFUSION AND ASCITES - REPORT OF A CASE TREATED WITH NAFARELIN ACETATE

      Journal of reproductive medicine
    79. YUZPE AA; NISKER JA; KAPLAN BR; TUMMON IS; AUCKLAND J
      NAFARELIN ACETATE FOR PITUITARY DOWN-REGULATION IN IN-VITRO FERTILIZATION - COMPARISON OF 2 DOSAGES

      Journal of reproductive medicine
    80. CANNON JB; KRILL SL; PORTER WR
      PHYSICOCHEMICAL PROPERTIES OF A-75998, AN ANTAGONIST OF LUTEINIZING-HORMONE-RELEASING HORMONE

      Journal of pharmaceutical sciences
    81. HORNSTEIN MD; YUZPE AA; BURRY KA; HEINRICHS LR; BUTTRAM VL; ORWOLL ES
      PROSPECTIVE RANDOMIZED DOUBLE-BLIND TRIAL OF 3 VERSUS 6 MONTHS OF NAFARELIN THERAPY FOR ENDOMETRIOSIS-ASSOCIATED PELVIC PAIN

      Fertility and sterility
    82. NELSON LR; FUJIMOTO VY; JAFFE RB; MONROE SE
      SUPPRESSION OF FOLLICULAR PHASE PITUITARY-GONADAL FUNCTION BY A POTENT NEW GONADOTROPIN-RELEASING-HORMONE ANTAGONIST WITH REDUCED HISTAMINE-RELEASING PROPERTIES (GANIRELIX)

      Fertility and sterility
    83. SURREY ES; VOIGT B; FOURNET N; JUDD HL
      PROLONGED GONADOTROPIN-RELEASING-HORMONE AGONIST TREATMENT OF SYMPTOMATIC ENDOMETRIOSIS - THE ROLE OF CYCLIC SODIUM ETIDRONATE AND LOW-DOSENORETHINDRONE ADD-BACK THERAPY

      Fertility and sterility
    84. WRIGHT S; VALDES CT; DUNN RC; FRANKLIN RR
      SHORT-TERM LUPRON OR DANAZOL THERAPY FOR PELVIC ENDOMETRIOSIS

      Fertility and sterility
    85. NEWHALLPERRY K; HOLLOWAY L; OSBURN L; MONROE SE; HEINRICHS L; HENZL M; MARCUS R
      EFFECTS OF A GONADOTROPIN-RELEASING-HORMONE AGONIST ON THE CALCIUM-PARATHYROID AXIS AND BONE TURNOVER IN WOMEN WITH ENDOMETRIOSIS

      American journal of obstetrics and gynecology
    86. RAVN P; BERGQVIST A; HANSEN MA; OVERGAARD K; CHRISTIANSEN C
      TREATMENT OF ENDOMETRIOSIS WITH THE LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST NAFARELIN - EFFECT ON BONE TURNOVER AND BONE MASS

      Menopause
    87. ADAMSON GD; KWEI L; EDGREN RA
      PAIN OF ENDOMETRIOSIS - EFFECTS OF NAFARELIN AND DANAZOL THERAPY

      International journal of fertility and menopausal studies
    88. GONI MH; MARKUSSIS V; TOLIS G
      OCTREOTIDE EFFECT ON OVARIAN MORPHOLOGY IN INSULIN-RESISTANT PCOS PATIENTS FOLLOWING 6-MONTH DECAPEPTYL TREATMENT

      American journal of reproductive immunology [1989]
    89. COLOMBO P; AMBROSI B; SACCOMANNO K; BASSETTI M; CORTELAZZI D; FAGLIA G
      EFFECTS OF LONG-TERM TREATMENT WITH THE GONADOTROPIN-RELEASING-HORMONE ANALOG NAFARELIN IN PATIENTS WITH NONFUNCTIONING PITUITARY-ADENOMAS

      European journal of endocrinology
    90. CHARBONNEL B
      ANALOGS OF GONADOTROPIN-RELEASING-HORMONE - PHYSIOLOGY AND THERAPEUTIC APPLICATIONS

      La Presse medicale
    91. DELGADOCHARRO MB; GUY RH
      CHARACTERIZATION OF CONVECTIVE SOLVENT FLOW DURING IONTOPHORESIS

      Pharmaceutical research
    92. HULL ME; BARBIERI RL
      NAFARELIN IN THE TREATMENT OF ENDOMETRIOSIS - DOSE MANAGEMENT

      Gynecologic and obstetric investigation
    93. ROY SD; DEGROOT JS
      PERCUTANEOUS-ABSORPTION OF NAFARELIN ACETATE, AN LHRH ANALOG, THROUGHHUMAN CADAVER SKIN AND MONKEY SKIN

      International journal of pharmaceutics
    94. OHAGAN DT; JEFFERY H; DAVIS SS
      THE PREPARATION AND CHARACTERIZATION OF POLY(LACTIDE-CO-GLYCOLIDE) MICROPARTICLES .3. MICROPARTICLE POLYMER DEGRADATION RATES AND THE IN-VITRO RELEASE OF A MODEL PROTEIN/

      International journal of pharmaceutics
    95. PICKERSGILL A; KINGSLAND CR; GARDEN AS; FARQUHARSON RG
      MULTIPLE GESTATION FOLLOWING GONADOTROPIN-RELEASING-HORMONE THERAPY FOR THE TREATMENT OF MINIMAL ENDOMETRIOSIS

      British journal of obstetrics and gynaecology
    96. DAMARIO MA; ROCK JA
      GOSERELIN (ZOLADEX) VERSUS DANAZOL FOR ENDOMETRIOSIS - THE NORTH-AMERICAN EXPERIENCE

      British journal of obstetrics and gynaecology
    97. FOGELMAN I; FENTIMAN I; HAMED H; STUDD JWW; LEATHER AT
      GOSERELIN (ZOLADEX) AND THE SKELETON

      British journal of obstetrics and gynaecology
    98. EDMONDS DK; HOWELL R
      CAN HORMONE REPLACEMENT THERAPY BE USED DURING MEDICAL THERAPY OF ENDOMETRIOSIS

      British journal of obstetrics and gynaecology
    99. GONI M; MARKUSSIS V; TOLIS G
      EFFICACY OF CHRONIC THERAPY WITH THE GONADOTROPIN-RELEASING-HORMONE AGONIST DECAPEPTYL IN PATIENTS WITH POLYCYSTIC-OVARY-SYNDROME

      Human reproduction
    100. GOLDMAN JA; DICKER D; FELDBERG D; ASHKENAZI J; VOLIOWICH I
      A PROSPECTIVE RANDOMIZED COMPARISON OF 2 GONADOTROPIN-RELEASING-HORMONE AGONISTS, NAFARELIN ACETATE AND BUSERELIN ACETATE, IN IN-VITRO FERTILIZATION-EMBRYO TRANSFER

      Human reproduction


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 02:57:57